SCHEMBL3056571

SCHEMBL3056571

COc1cc2c(cc1OCc1ccccc1)CCN(C(=O)c1ccccc1OC)C2

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.69
HSD17B10 Q99714 2/20 0.69
ALOX15 P16050 1/20 0.69
PDE4B Q07343 3/20 0.65
CHRNA7 P36544 2/20 0.64
GPR183 P32249 1/20 0.62
KMT2A Q03164 2/20 0.62
NPC1 O15118 1/20 0.62
MAPT P10636 2/20 0.58
ALDH1A1 P00352 2/20 0.58
MEN1 O00255 1/20 0.58
MDM2 Q00987 1/20 0.58
HCRTR2 O43614 3/20 0.57
ABCB1 P08183 1/20 0.56
LMNA P02545 2/20 0.55
HCRTR1 O43613 1/20 0.55
MAPK1 P28482 1/20 0.54
THRB P10828 1/20 0.54
TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9667825 0.87 CHRNA7 (0.69) KDM4EHSD17B10ALOX15CHRNA7GPR183
SCHEMBL9668362 0.87 CHRNA7 (0.69) KDM4EHSD17B10ALOX15CHRNA7GPR183
SCHEMBL9416605 0.86 LMNA (0.75) KDM4EHSD17B10ALOX15PDE4BCHRNA7
SCHEMBL3056795 0.85 KMT2A (0.62) KDM4EHSD17B10ALOX15PDE4BCHRNA7
SCHEMBL3041866 0.85 KMT2A (0.62) KDM4EHSD17B10ALOX15PDE4BCHRNA7
SCHEMBL3056740 0.85 KMT2A (0.68) KDM4EHSD17B10ALOX15PDE4BCHRNA7
SCHEMBL3055130 0.84 PDE4B (0.66) KDM4EHSD17B10ALOX15PDE4BCHRNA7
SCHEMBL3046120 0.82 KMT2A (0.63) KDM4EHSD17B10ALOX15PDE4BCHRNA7
SCHEMBL3052611 0.82 KDM4E (0.70) KDM4EHSD17B10ALOX15PDE4BKMT2A
SCHEMBL9416631 0.81 KMT2A (0.76) KDM4EHSD17B10ALOX15CHRNA7GPR183

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US claimed
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222299-A1 COMPOUND MKI67, VHL, MYC KDM4E 1083/4885HSD17B10 1303/4885ALOX15 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.